- Report
- June 2024
- 200 Pages
Global
From €7601EUR$7,950USD£6,363GBP
- Report
- October 2024
- 250 Pages
Global
From €4732EUR$4,949USD£3,961GBP
- Report
- January 2022
- 60 Pages
Global
From €3777EUR$3,950USD£3,161GBP
- Report
- May 2022
- 37 Pages
Global
From €1912EUR$2,000USD£1,601GBP
Tonic Clonic Seizure Drugs are a type of Central Nervous System (CNS) drug used to treat epilepsy. These drugs are used to reduce the frequency and severity of seizures, and can be used alone or in combination with other antiepileptic drugs. They work by blocking the spread of electrical signals in the brain that cause seizures. Commonly used Tonic Clonic Seizure Drugs include phenytoin, carbamazepine, valproic acid, and lamotrigine. These drugs are usually taken orally, but can also be administered intravenously.
The Tonic Clonic Seizure Drugs market is a subset of the larger CNS Drugs market. It is a highly competitive market, with many companies offering a variety of drugs to treat epilepsy. Some of the major players in the market include Pfizer, GlaxoSmithKline, Novartis, Sanofi, and Johnson & Johnson. Show Less Read more